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424a Tuesday, February 10, 2015G93A muscle during disease progression when the mice were on a regular diet.
As expected, an autophagy induction procedure (starvation plus colchicine)
enhanced autophagy flux in skeletal muscle of normal mice. However, in
response to the same autophagy induction procedure, G93A muscle showed
significant reduction in the autophagy flux. Immunoblot analysis revealed
that increased cleaved caspase-3 associated with apoptosis was linked to the
cleavage of several key proteins involved in autophagy, including Beclin-1,
which is an essential molecule connecting autophagy and apoptosis pathways.
Our data suggest that the cytoprotective autophagy pathway is suppressed in
G93A skeletal muscle and this suppression may link to the enhanced apoptosis
during ALS progression. The abnormal autophagy activity in skeletal muscle
likely contributes muscle degeneration and disease progression in ALS.
2131-Pos Board B268
Impairment in Acetylcholine Release by Cardiomyocytes Leads to
Enhanced Pathological Hypertrophy
Cibele Rocha-Resende1, Vania Prado2, Marco Prado2,
Aristobolo Mendes Silva3, Silvia Guatimosim1.
1Physiology, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil,
2Robarts Research Institute, London, ON, Canada, 3Morphology,
Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Our group has previously demonstrated that cardiomyocytes express ChAT
(choline acetyltransferase), VAChT (vesicular acetylcholine transporter) and
ChT-1 (choline high affinity transporter), proteins involved in the synthesis,
release and reuptake of acetylcholine. Additionally, we have shown that this
cardiomyocyte intrinsic cholinergic machinery has an important role in pre-
venting deleterious effects of adrenergic signaling in vitro and in vivo. To
address the role of this non-neuronal acetylcholine for heart function, a new
mouse lineage was generated with deletion of VAChT (vesicular acetylcholine
transporter) only in cardiac myocytes (cVAChT-ko). These mice are character-
ized by heart hypertrophy, calcium signaling dysfunction and increased reac-
tive oxygen species levels. In order to better understand how impairment in
acetylcholine released from cardiomyocytes could impact heart function, we
subjected these mice to transverse aortic constriction (TAC) and evaluated
left ventricular hypertrophy at 3 and 14 days after surgery. 3 days after TAC,
cardiac hypertrophy was more prominent in cVAChT-ko mice than in control
hearts (control: 11% versus cVAChT: 24%). However, 14 days after surgery,
heart and left ventricular hypertrophy were similar between cVAChT-ko
and control mice. Additionally, the lung/body ratio was significantly increased
only in cVAChT-ko with constriction (control: 9% versus cVAChT-ko: 54%),
suggesting that these mice present pulmonary edema, which is an indicative of
heart failure. Moreover, TAC induced an increase in PLN/SERCA ratio only in
cVAChT-ko mice. Thus our data show that cVAChT-ko mice is more prone to
cardiac disease under stress conditions than control mice, indicating that cardi-
omyocyte intrinsic cholinergic machinery plays an important role in cardiac
protection.
FINANCIAL SUPPORT: CNPq, FAPEMIG, NIH (Fogarty International
Award)
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Diseases of striated muscle linked to intermediate filament (IF) proteins are
associated with defects in the organization of the contractile apparatus and
its links to costameres, which connect the sarcomeres to the cell membrane.
Here we study the role in skeletal muscle of synemin, a type IV IF protein,
by examining mice null for synemin (synm-null). Synm-null mice have a
mild skeletal muscle phenotype. Tibialis anterior muscles show a significant
decrease in mean fiber diameter, in twitch and tetanic tension and an increase
in susceptibility to injury caused by lengthening contractions. Organization of
proteins associated with the contractile apparatus and costameres is not signif-
icantly altered in the synm-null. Elastimetry of the sarcolemma and associated
contractile apparatus in extensor digitorum longus myofibers reveals a reduc-
tion in stiffness consistent with an increase in sarcolemmal deformability.
Although fatigue with repeated isometric contractions is greater in isolated
TA muscles of synm-null mice, the ability of the mice to run uphill on a tread-
mill is similar to controls. Our results show that synemin contributes to linkage
between costameres and the contractile apparatus, and that the absence of syn-
emin results in decreased fiber size and increased sarcolemmal deformability
and susceptibility to injury. Synemin plays a moderate but distinct role in
fast twitch skeletal muscle. Supported partially by a Physiological Genomicsand a CONACyT fellowship to KPGP, and by NIH to RML (R01 AR
059179), to MB (RO1 02520711), and to RJB (R01 AR 055928).
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Increased reactive oxygen species (ROS) are a hallmark of many diseases, such
as inflammatory myopathies. Recent evidence suggests elevated cytokine activ-
ity increases ROS production resulting in muscle weakness; however, the spe-
cific source of ROS production has yet to be fully elucidated. Redox sensitive
probes, targeted to NADPH oxidase 2 (Nox2) (p47-roGFP) and the mitochon-
dria (mito-roGFP), were used to assess the sub-cellular site of ROS production
in the presence of various cytokines. In addition, we assessed the effect of
cytokine induced ROS production on skeletal muscle function. Cytokine stim-
ulation increased p47-roGFP oxidation approximately 15%, but had no effect
on mito-roGFP oxidation. Genetic and pharmacological inhibition of Nox2
resulted in decreased Nox2-dependent ROS production while genetic overex-
pression of SOD2 had no effect on mitochondrial or Nox2-mediated ROS pro-
duction. Following cytokine administration, skeletal muscle function decreased
by 30% and genetic inhibition of Nox2-activity partially rescued muscle func-
tion. Genetic inhibition of mitochondrial-ROS provided no protection against
decreased muscle function following cytokine stimulation. Collectively, these
data indicate that elevated cytokine activity resulted in increased ROS produc-
tion at specific sub-cellular sites, negatively affecting muscle function. Our data
highlight the importance of understanding the source of ROS production
in response to physiological and/or pathological stimuli such that targeted
therapeutic approaches can be developed to combat the deleterious effects of
oxidative stress.
Mechanisms of Voltage Sensing and Gating
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The structure of an Hv1-based chimeric voltage sensor protein (mHv1cc) was
recently solved by X-ray crystallography. Although mHv1cc mediates voltage-
gated Hþ currents when expressed in mammalian cells, the crystallized pro-
tein likely represents a closed, possibly resting, conformation. However, the
mHv1cc structure is apparently incompatible with our experimental measure-
ments of the resting-state Hþ ‘shuttle’ conductance (GSH) in hHv1 R205H.
In order to explore possible conformations of the Hv1 voltage sensor (VS)
domain in its resting state, we created an Hv1 VS domain homology model
(Hv1 D) based on a previously reported resting-state Rosetta model structure
of the Shaker Kþ channel VS domain (Pathak, et al. 2007) and subjected the
Hv1 model to all-atom MD simulations. We subsequently created a model of
the Hv1 D R205H point mutant that mediates GSH. In contrast to mHv1cc
and a resting-state model of the Ciona Hv1 VS domain (Chamberlin, et al.
2013), the central crevice in our new model is not obviously occluded by hy-
drophobic side chains. A prominent feature of Hv1 D R205H is that the imid-
azole ring of the introduced histidine appears to be simultaneously accessible to
intra- and extra-cellular aqueous vestiblues, and therefore appears competent
for Grotthuss-type proton conduction. Hv1 D represents the first VS domain
resting-state model structure that satisfies the rigorous structural constraints
imposed by experimental data and thus serves as a template for understanding
the structural basis of VS activation in a variety of VS domain-containing
proteins.
2135-Pos Board B272
Unveiling Potential Binding Sites in the Hv1 Four Helix Bundle
Eleonora Gianti1, Lucie Delemotte1, Vincenzo Carnevale1,
Francesco Tombola2, Douglas Tobias2, Michael L. Klein1.
1Chemistry and the ICMS, Temple University, Philadelphia, PA, USA,
2University of California, Irvine, CA, USA.
Hv1 is a voltage-sensor protein that plays essential roles in proton conduction,
pH homeostasis and production of high-level superoxide by phagocytes.
Unregulated Hv1 activity has pathological implications, such as hyper-
proliferation of cancer cells and exacerbation of brain damage in ischemic
stroke.
Tuesday, February 10, 2015 425aUnlike other voltage-gated ion channels, Hv1 is composed by two subunits
each containing a voltage-sensing domain (VSD) and lacking the pore domain.
On the other hand, Hv1 shares striking similarities with the M2 proton channel
of the influenza A virus (A/M2): in both cases a bundle of four helices lines a
proton conduction pathway and positively charged ‘‘fragment-like’’ molecules
act as blockers.
Starting from the recently solved structure of Hv1, we combined homology
modeling, molecular dynamics simulations and site finding methods to unveil
potential binding pockets in the most relevant conformational states. We
discovered that, similarly to the case of A/M2, the distribution of water mole-
cules inside the channel lumen is state-dependent, offering a rationale to
designing novel pore blockers.
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The Hv1 channel extrudes protons from cells in response to membrane depolar-
ization, and regulates the production of reactive oxygen species by NOX en-
zymes. Its excessive activity has been implicated in cancer development and
in brain damage during ischemic stroke. The channel is a dimeric complex
made of two voltage-sensing domains (VSDs), each containing a gated proton
permeation pathway. We have previously identified 2-guanidinobenzymida-
zole (2GBI) derivatives that block proton permeation through the two VSDs
(Hong et al. 2013, Neuron 77(2): 274-286). For these compounds, the binding
occurs independently in the two open subunits, and resembles the binding to a
monomeric version of the channel. Here we describe a separate class of guani-
dine derivatives - 2-guanidinothiazoles - that block Hv1 in a cooperative way.
Comparison of the dose dependences of inhibition of dimeric and monomeric
channels shows that blocker binding to one open subunit causes an increase in
binding affinity of the neighboring open subunit. Using a site-directed muta-
genesis approach, we identify the residues in the binding site responsible for
cooperativity and then explore the residues at the interface between subunits
that mediate allosteric coupling in the open state. Understanding the molecular
features of the inhibitor that modulate cooperative binding can help develop
better drugs targeting the Hv1 channel. This work is supported by NIH -Na-
tional Institute of General Medical Sciences, grant R01GM098973.
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In 1972, J. Woodland Hastings and colleagues predicted the existence of a pro-
ton selective channel that opens in response to depolarizing voltage (HV1)
across the vacuole membrane of bioluminescent dinoflagellates and conducts
protons into specialized luminescence compartments (scintillons), thus causing
the pH drop that triggers the light flash. RNA-Seq data from several lumines-
cent dinoflagellate species provided candidate HV1 genes. When expressed in
mammalian cells, the predicted HV1 from Lingulodinium polyedrum
displays the hallmark properties of bona fide proton channels, including
time-dependent opening with depolarization, perfect proton selectivity, and
characteristic DpH dependent gating. RT-PCR and Western blotting confirm
expression of HV1 in L. polyedrum. Fluorescence confocal microscopy of L.
polyedrum cells stained with antibodies to luminescence proteins luciferase
and luciferin binding protein and to HV1 reveal structures consistent with
HV1’s proposed function in bioluminescence.
[Supported by NSF: MCB-1242985, NIH: GM102336,/]
2138-Pos Board B275
Engineered Voltage Sensing Phosphatases: What do they tell us about the
Gating Mechanism?
Angeliki Mavrantoni, Kirstin Hobiger, Michael G. Leitner, Dominik Oliver,
Christian R. Halaszovich.
Neurophysiology, Philipps-University Marburg, Marburg, Germany.
Voltage sensing phosphatases (VSPs) contain a phosphoinositide phosphatase
domain (PD), which is under the control of a voltage sensor domain (VSD).Here, the underlying coupling mechanism is not fully understood. Recently,
Liu et al. (NSMB 2012) and Hobiger et al. (Biophys J 2012, PLoS one 2013)
proposed for Ciona intestinalis (Ci-) VSP an interaction of positively charged
amino acid residues in the linker, which connects the PD to the VSD, with
the negatively charged residue Asp400 in the ‘TI’ loop of the PD.
In light of these findings we revisited the engineered VSPs PTENCiV (Lacroix
et al., JBC 2011) and hVSP1CiV (Halaszovich et al., J Lipid Res 2012),
chimeras consisting of Ci-VSP’s VSD and the PD of PTEN or hVSP1, respec-
tively. In those chimeras Asp400 (Ci-VSP numbering) is not conserved. None-
theless, they show robust voltage dependent phosphatase activity. Mutations
within the linker showed effects mirroring those previously reported for Ci-
VSP, suggesting a gating mechanism similar to the one found in wild-type
Ci-VSP. We mutated Asp400 in Ci-VSP to Asn or Arg and the corresponding
Asn (hVSP1) or Arg (PTEN) in the chimeric enzymes to Asp and measured
their voltage dependent enzymatic activity as well as sensing currents to eluci-
date the importance of Asp400 for VSD-PD-coupling.
We propose that the interactions involving Asp400 described by Liu et al.
and Hobiger et al. are not a necessary prerequisite for the voltage dependent
activation of VSPs, but allow for a more efficient VSD-to-PD coupling. Further
work will be required to establish the essential interactions between VSP,
linker, and PD.
Supported by Deutsche Forschungsgemeinschaft (DFG, grant SFB 593, TP12
to D.O.) and University Medical Center Giessen and Marburg (UKGM, grant
32/2011MR to C.R.H.)
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The voltage-sensing phosphatase (VSP) is a voltage-activated enzyme that de-
phosphorylates phosphatidylinositol phosphates (PIPs). VSP is unique because
it is the only example of an enzyme activated by voltage, providing the first
direct link between lipid signaling pathways and membrane potential. Along
with the voltage sensing domain, VSP also has a catalytic domain and a C2
domain. To date, the role of the VSP C2 domain is not understood. C2 domains
are generally known as lipid binding domains, however, previous work has sug-
gested the VSP C2 has a role in catalytic activity. Specifically, the crystal struc-
tures [1,2] show the 522-loop of the C2 forms a portion of the enzyme active
site and the mutation Y522A altered enzyme activity [2]. We further probed
the role of Y522 by introducing a phenylalanine instead of an alanine. We
found the Y522F mutation also shifts the voltage dependence of catalytic activ-
ity, suggesting that hydrogen bonding is not a factor when this residue partic-
ipates in VSP activity. A role in catalysis does not exclude the VSP C2 from
also contributing to lipid binding. To investigate this possibility, we started
by fully deleting the C2 domain from Ci-VSP and found that the presence of
the full C2 domain is necessary for normal phosphatase function. We then com-
bined more specific C2 mutations with the ability to manipulate PIP concentra-
tions using a rapamycin-induced system in order to further address the possible
roles of the C2 in VSP function. Our goal is to investigate how the C2 domain
contributes to VSP function.
[1] Matsuda, M. et al. JBC, 286, 23368-77 (2011).
[2] Liu, L. et al. NSMB, 19, 633-641 (2012).
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We have identified a protein coded by the C15orf27 gene that we named NVS
(Novel Voltage Sensor). NVS contains 531 residues, and contains an S1-S4
domain, a 90 residue N-terminus and a 307 residue C-terminus, both of which
are predicted to be intracellular. The most critical residues found in S1-S4 do-
mains of other voltage sensors are conserved in NVS, including 3 Arg and a Lys
in the S4 helix, 4 conserved acidic residues in S1-S3 and the charge-transfer
Phe in S2. In addition, the C-terminus is predicted to contain a coiled-coil
domain, similar to voltage-activated proton (Hv1) channels. Our hypothesis
is that NVS functions as a voltage sensor that couples to intracellular signaling
pathways or interacts with Hv1 to form heteroligomers through the C-terminal
coiled-coil domain. We used site-specific voltage-clamp fluorometry and iden-
tified several positions at the outer ends of S3 and S4 where labeled Cys resi-
dues produced changes in fluorescence as a function of membrane potential.
Several positions give complex fluorescence responses, starting with a rapid in-
crease in fluorescence followed by slower decrease in fluorescence. We also
investigated whether NVS can oligomerize with Hv1, but observe no change
